drugset / Trial / NCT07022821

Comparison of Dexmedetomidine + Ketamine for Postoperative Pain in C-Section

NCT07022821

Phase 4 Recruiting 90 enrolled Fatima Memorial Hospital
RandomizedParallel-groupDouble-blindTreatment

Summary

This study aims to compare three different doses of dexmedetomidine, when combined with a fixed dose of ketamine, for pain control in women undergoing cesarean section. The goal is to find the most effective combination with the fewest side effects.

Timeline

Start
2025-05-16
Primary completion
2025-08-16
Completion
2025-08-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.2 ug/kg Intravenous
Subject Dexmedetomidine Other / unclassified 0.3 ug/kg Intravenous
Subject Dexmedetomidine Other / unclassified 0.4 ug/kg Intravenous
Background Ketamine Small molecule 0.25 mg/kg Intravenous

Indications

No indication recorded.